Zobrazeno 1 - 10
of 10
pro vyhledávání: '"J. L. Rueda Garcia"'
Autor:
M. D. Martin-Arranz, L. García-Ramírez, M. Hernandez-Perez, D. Montero Vega, E. Martín-Arranz, M. Sánchez-Azofra, J. Poza Cordon, J. L. Rueda Garcia, J. Noci Belda, T. Verges Martínez-Meco, P. Blanco San Miguel, C. Suarez Ferrer
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Patients with inflammatory bowel disease (IBD) treated with biologic and/or immunosuppressant drugs are at increased risk for opportunistic infections. Seroprevalence studies can confirm the diagnosis of SARS-CoV-2 infections as well as the
Externí odkaz:
https://doaj.org/article/efcb1819ab6e4a0593b0272ac1fe66f2
Autor:
L García Ramírez, C Suárez Ferrer, J L Rueda Garcia, E Martín-Arranz, J Poza Cordón, M Sánchez-Azofra, M D Martin-Arranz
Publikováno v:
Journal of Crohn's and Colitis. 17:i952-i953
Background Given the low immunogenicity of ustekinumab (UST), it has been suggested that it is not necessary to add an immunomodulator (IMM). However, there is little scientific evidence on whether the efficacy of combined UST+IMM treatment may be gr
Autor:
M D Martin Arranz, L García Ramírez, D Montero Vega, E Martín-Arraz, M Sánchez Azofra, J Poza Cordon, J L Rueda Garcia, J Noci Belda, T Verges Martínez-Meco, P Blanco San Miguel, C Suarez Ferrer
Publikováno v:
Journal of Crohn's and Colitis. 16:i533-i534
Background Our objective is to evaluate the serologic response to the SARS-CoV-2 vaccine in patients with Inflammatory Bowel Disease (IBD). In addition to that, we want to analyze the influence of immunosuppressive drugs in that response, as well as
Autor:
J Rueda Sanchez, C J Suarez Ferrer, J Poza Cordon, S Camara Baena, A Keco Huerga, J Garcia de la Borbolla Serres, E Martin Arranz, M Sanchez Azofra, J L Rueda Garcia, L Garcia Ramirez, J Noci Belda, T Verges Martinez-Meco, M D Martin Arranz
Publikováno v:
Journal of Crohn's and Colitis. 16:i251-i252
Background Gastrointestinal ultrasound (GIUS), applied to Crohn`s Disease, has proven correlation with imaging studies and endoscopy in terms of diagnosis, follow-up and evaluation of transmural complications. However, real-world data about Ulcerativ
Autor:
C Suarez Ferrer, M Sanchez Azofra, J L Rueda Garcia, C Amiama Roig, C Amor Costa, I González Díaz, J Poza Cordón, M D Martín Arranz, L. Garcia Ramirez, E. Martín Arranz
Publikováno v:
Journal of Crohn's and Colitis. 15:S462-S463
Background Chronic inflammatory diseases, including the Inflammatory Bowel Disease (IBD), show an increased risk in the development of atherosclerotic cardiovascular disease and coronary microvascular dysfunction at an early age. AntiTNF α have pro
Autor:
J L Rueda Garcia, J Poza Cordón, M Sanchez Azofra, L. Garcia Ramirez, C Suarez Ferrer, M D Martín Arranz, E. Martín Arranz
Publikováno v:
Journal of Crohn's & Colitis
Background Colonic neoplastic risk is increased in long-standing colitis. Chromoendoscopy (CE) is the recommended screening method. Narrow band imaging (NBI) is potentially a more convenient alternative. Few studies have explored the diagnostic yield
Autor:
J L Rueda Garcia, B Poladura, C Suarez Ferrer, L Garcia-Ramirez, Joaquín Poza, Jesus Noci, María Sánchez-Azofra, María Dolores Martín-Arranz, E. Martin-Arranz, T Verges
Publikováno v:
Journal of Crohn's and Colitis. 14:S229-S230
Background Colonoscopy is the first-line procedure for the diagnosis and management of inflammatory bowel disease (IBD). Data regarding bowel preparation in patients with IBD are scarce. Our aim was to evaluate efficacy, safety and tolerability of th
Autor:
C Suarez Ferrer, J. Noci Belda, E. Martín Arranz, M Sanchez Azofra, J L Rueda Garcia, J Poza Cordón, O Crivillen Anguita, L. Garcia Ramirez, M D Martín Arranz
Publikováno v:
Journal of Crohn's and Colitis. 14:S278-S279
Background The ‘treat to target’ strategy for managing patients with Crohn’s disease (CD) requires simple, reliable and non-invasive monitoring tools. Bowel ultrasound is an emerging technology that could be useful in this field. The aim of our
Autor:
C Suárez, E Martin-Arranz, P Mayor, J L Rueda-Garcia, M Sanchez-Azofra, M A Ruiz-Ramirez, J Poza, María Dolores Martín-Arranz, M Cuadros, L Garcia-Ramirez
Publikováno v:
Journal of Crohn's and Colitis. 14:S378-S378
Background Malnutrition is a frequent problem in inflammatory bowel disease (IBD) due to the increase in caloric consumption because of the pathology itself and due to the reduced intake. This low intake is mainly caused by the symptoms and the anore
Autor:
L Garcia-Ramirez, Diana Peiteado, Alejandro Balsa, J L Rueda-Garcia, K. Franco, P. Rodríguez-Merlos, E. Martin-Arranz, Joaquín Poza, María Sánchez-Azofra, M A Ruiz-Ramirez, María Dolores Martín-Arranz, Chamaida Plasencia-Rodríguez, Navarro-Compán, C Suárez, Gemma Bonilla
Publikováno v:
Journal of Crohn's and Colitis. 14:S473-S473
Background Vedolizumab is a monoclonal antibody that binds to an integrin resulting in gut-selective anti-inflammatory activity. It is indicated for the treatment of inflammatory bowel disease (IBD), both in Crohn’s disease (CD) and ulcerative coli